Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Formin-SR 500 Tablet

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Metformin (500mg)

Overview Formin-SR 500 Tablet

Metformin extended-release 500mg tablets manage type 2 diabetes by regulating blood glucose, mitigating diabetes-related complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. To minimize gastrointestinal upset, ingest this medication with food, consistently at the same time daily for optimal efficacy. Discontinue use only under physician guidance. Maintaining a healthy lifestyle is crucial for diabetes management; adhere to your doctor's dietary and exercise plan. Common side effects may include diarrhea, nausea, vomiting, gas, fatigue, indigestion, stomach discomfort, headache, and appetite loss. Concurrent use with other diabetic medications, alcohol consumption, or missed meals increases hypoglycemia risk; regular blood glucose monitoring is essential. Inform your physician of any kidney, liver, or heart conditions before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Kidney function testing precedes treatment initiation. Limit alcohol consumption to reduce potential side effects.

Uses of Formin-SR 500 Tablet

Managing type 2 diabetes and polycystic ovary syndrome (PCOS)

Major Benefits of Formin-SR 500 Tablet:

Follow your doctor's instructions or consult the product label for usage guidelines. Administer Formin-SR 500 Tablet with a meal.

Common Side effects of Formin-SR 500 Tablet:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Formin-SR 500 Tablet:

Always follow your physician's instructions or consult the product labeling for proper administration. The Formin-SR 500 Tablet should be ingested with a meal.

How Formin-SR 500 Tablet works:

Metformin extended-release 500mg tablets are a type 2 diabetes treatment from the biguanide class. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Formin-SR 500 Tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Formin-SR 500 Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Use of Formin-SR 500mg tablets during breastfeeding requires careful consideration. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Formin-SR 500mg tablets cautiously, potentially requiring dosage modification under medical supervision. Formin-SR 500mg tablets are contraindicated in individuals with severely compromised kidney function.

LiverLiverUNSAFE

Patients with liver disease should likely avoid Formin-SR 500 Tablets due to potential safety concerns. A physician's consultation is advised.

What if you forget to take Formin-SR 500 Tablet :

Should you forget a Formin-SR 500 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Formin-SR 500 Tablet

LabelValue
Type of Compound Biguanide-based medication
Addictive None.
Medication Classification Medication for diabetes

FAQs on Formin-SR 500 Tablet

Individuals with type 2 diabetes exhibit impaired responsiveness to their body's self-produced insulin. This results in elevated blood glucose concentrations. Formin-SR 500 Tablet employs a multifaceted approach to lower these increased sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption post-meal, and enhances insulin sensitivity in muscles and other organs. This combined action facilitates improved glucose uptake from the bloodstream and optimizes the body's natural insulin utilization.
Indeed, clinical evidence indicates Formin-SR 500 Tablets can lead to weight reduction in overweight or obese patients. This weight loss effect may also be observed, albeit less significantly, in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience similar weight loss. However, self-initiation of this medication for weight management is strongly discouraged; physician consultation is essential.
Metformin extended-release 500 mg is frequently an initial treatment for hyperglycemia. This medication manages blood glucose by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, monotherapy with metformin extended-release 500 mg infrequently results in hypoglycemia due to its mechanism of action, which does not stimulate excessive insulin release. Beyond glycemic control, it also assists in weight management.
Metformin extended-release 500 mg tablets typically do not induce drowsiness and are generally well-received. Nevertheless, in rare instances, the medication may result in sleep disturbances and insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, particularly prevalent in individuals with impaired renal function. Seek medical advice if fatigue or sleepiness develops during treatment with metformin extended-release 500 mg tablets.
Administer Formin-SR 500 Tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, take it in the morning with breakfast. For twice-daily prescriptions, divide the dose between morning and evening meals. For thrice-daily prescriptions, distribute the tablets with breakfast, lunch, and dinner. Consuming Formin-SR 500 Tablets with food mitigates potential gastrointestinal distress such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their body's own insulin. This results in elevated blood sugar (glucose) levels. Formin-SR 500 Tablet works through multiple mechanisms to lower these high blood sugar levels. Specifically, it reduces glucose production by the liver, diminishes intestinal glucose absorption following meals, and enhances the insulin sensitivity of tissues and muscles. This improved sensitivity facilitates better glucose uptake from the bloodstream. Consequently, the body's natural insulin becomes more effective.
Indeed, clinical evidence indicates Formin-SR 500 Tablets can lead to weight reduction in overweight or obese patients. This weight loss effect may also be observed, albeit less dramatically, in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience weight reduction. However, self-medicating with this drug for weight management is strongly discouraged; physician consultation is essential.
Metformin extended-release 500 mg tablets are frequently an initial treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Unlike some other oral hypoglycemics, monotherapy with metformin extended-release 500 mg tablets infrequently results in hypoglycemia due to its mechanism of action which avoids excessive pancreatic insulin release. Beyond glycemic control, it also aids in mitigating weight increase.
Metformin extended-release 500 mg tablets typically do not induce drowsiness and are generally well-tolerated. Nevertheless, in rare instances, this medication may lead to sleep disturbances and insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Seek medical attention if fatigue or sleepiness develops during treatment with metformin extended-release 500 mg tablets.
Administer Formin-SR 500 tablets during or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, morning administration with breakfast is recommended. Twice-daily regimens should involve one tablet with breakfast and the other with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Formin-SR 500 with food mitigates potential gastrointestinal issues such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either insufficiently produce insulin or exhibit impaired responsiveness to their endogenous insulin. This results in elevated blood glucose. Formin-SR 500 Tablet works through multiple mechanisms to lower these high blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues. This combined action facilitates improved glucose uptake from the bloodstream. The tablet also promotes a more effective response to naturally produced insulin.
Indeed, clinical evidence indicates that Formin-SR 500 Tablets can lead to weight reduction in overweight or obese patients. This weight loss effect may also be observed, albeit modestly, in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience weight loss as a result. However, self-initiation of this medication for weight management is strongly discouraged. Always seek medical advice before commencing treatment.
Metformin extended-release 500 mg tablets are frequently a first-line treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Unlike some other oral hypoglycemics, monotherapy with metformin extended-release 500 mg tablets infrequently results in hypoglycemia due to its mechanism of action, which does not stimulate excessive insulin release. Beyond glycemic control, it also aids in weight management.
Formin-SR 500 Tablets typically do not induce drowsiness and are generally well-received. Infrequently, however, Formin-SR 500 Tablet use can lead to sleep disturbances and insomnia. Somnolence may signal a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Formin-SR 500 Tablet administration.
Administer Formin-SR 500 tablets during or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, take the tablet in the morning with breakfast. If twice-daily dosing is prescribed, take one tablet with breakfast and the second with dinner. For thrice-daily dosing, distribute the tablets with breakfast, lunch, and dinner. Consuming Formin-SR 500 with food mitigates potential gastrointestinal discomfort such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Formin-SR 500 Tablet
29
MRP 34
13% off